Published Papers

Below is a listing of selected recently published papers by Dr. Gregory T. Everson, and in collaboration with industry peers:

Feb. 8, 2021 — Predicting clinical decompensation in patients with cirrhosis using the Hepquant‐SHUNT test | Mohammad Amin Fallahzadeh Daniel J. Hansen James F. Trotter Gregory T. Everson Giovanna Saracino Robert S. Rahimi Steve Helmke Jodi Boutte Sumeet K. Asrani | Alimentary Pharmacology and Therapeutics

Jan. 2, 2021 —  The within-individual reproducibility of the disease severity index from the HepQuant SHUNT test of liver function and physiology. Burton JR Jr, Helmke S, Lauriski S, Kittelson J, Everson GT. | Transl Res. 2021 Jan 2;S1931-5244(20)30321-2. doi: 10.1016/j.trsl.2020.12.010.

Nov. 2020 — Clinical Research in Hepatology in the COVID-19 Pandemic and Post-Pandemic Era: Challenges and the Need for Innovation | Verna EC, Serper M, Chu J, Corey K, Fix OK, Hoyt K, Page KA, Loomba R, Li M, Everson GT, Fried MW, Garcia-Tsao G, Terrault N, Lok AS, Chung RT, Reddy KR. | Hepatology 2020 Nov;72(5):1819-1837. doi: 10.1002/hep.31491.

Aug. 4, 2020 — Deterioration in Liver Function after Liver-Directed Therapy for Hepatocellular Carcinoma Measured by Cholate Clearance (University of Pennsylvania) | Division of Gastroenterology and Hepatology | Accepted Aug. 4, 2020

Jul. 16, 2019 — Assessing Hepatic Impairment in Fontan‐Associated Liver Disease Using the HepQuant SHUNT Test  |Division of Gastroenterology & Hepatology, Department of Medicine, Northwestern University Feinberg School of Medicine | Accepted July 16, 2019 | Congenit Heart Dis. 2019 Aug 1. doi: 10.1111/chd.12831.

May 2015 — Noninvasive assessment of liver function | Helmke S, Colmenero J, Everson GT. Curr Opin Gastroenterol. | 2015 May;31(3):199-208.

Mar. 2013 — Functional elements associated with hepatic regeneration in living donors after right hepatic lobectomy | Gregory T. Everson, John C. Hoefs, Claus U. Niemann, Kim M. Olthoff, Robert Dupuis, Shannon Lauriski, Andrea Herman, Norah Milne, Brenda W. Gillespie, Nathan P. Goodrich, and James E. Everhart. | Liver Transpl 2013; 19:292–304.

Apr. 2012 — Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: results from the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis Trial | Gregory T. Everson, Mitchell L. Shiffman, John C. Hoefs, Timothy R. Morgan, Richard K. Sterling, David A. Wagner, Shannon Lauriski, Teresa M. Curto, Anne Stoddard, and Elizabeth C. Wright, the HALT-C Trial Group. | Hepatology 2012; 55:1019-1029.

Apr 2009 — Hepatitis C Virus: A Critical Appraisal of Approaches to Therapy. | Nelson, D.R., Davis, G.L., Jacobson, I. Everson, G.T., Fried, M.W., Harrison, S.A., Hassanein, T., Jensen, D.M., Lindsay, K.L., Terrault, N., Zein, N (2008). | Clin Gastroenterol Hepatol. 7(4):397-414. PMID: 19114127

Dec. 4, 2008 — Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon | Di Bisceglie, A.M., Shiffman, M.L., Everson, G.T., Lindsay, K.L., Everhart, J.E., Wright, E.C., Lee, W.M., Lok, A.S., Bonkovsky, H.L., Morgan, T.R., Ghany, M.G., Morishima, C., Snow, K.K., Dienstag, J.L., and the HALT-C Trial Group (2008). | New England Journal of Medicine, 359(23):2429-2441. PMCID: PMC2606037.

Dec. 1, 2008 — Quantitative Tests of Liver Function Measure Hepatic Improvement after Sustained Virologic Response: Results from the HALT-C Trial.  | Everson, G.T., Shiffman, M.L., Hoefs, J.C., Morgan, T.R., Sterling, R.K., Wagner, D.A., DeSanto, J.L., Curto, T., Wright, E.C., and the HALT-C Trial Group (2009) | Aliment Pharmacol Ther., 29(5):589-601. PMCID: PMC3767280.

May 27, 2008 — The Spectrum of Hepatic Functional Impairment in Compensated Chronic Hepatitis C: Results from the HALT-C Trial. G T Everson 1, M L Shiffman, T R Morgan, J C Hoefs, R K Sterling, D A Wagner, C C Kulig, T M Curto, E C Wright, Halt-C Trial Group | Aliment Pharmacol Ther. 27(9):798-809.

Aug. 1, 2007 — Portal-systemic Shunting in Patients with Fibrosis or Cirrhosis due to Chronic Hepatitis C: the Minimal Model for Measuring Cholate Clearances and Shunt | G T EversonM A MartucciM L ShiffmanR K SterlingT R MorganJ C HoefsHALT-C trial group | Aliment Pharmacol Ther, 26(3):401-10. PubMed PMID: 17635375.


Below is a listing of books either written or contributed by Dr. Gregory T. Everson.

Living with Hepatitis B: A Survivor’s Guide
Living with Hepatitis C: A Survivor’s Guide
Living with Hemochromatosis:
Expert Answers to Your Questions about Iron Overload
Liver Transplantation:
Challenging Controversies and Topics
My Mom Has Hepatitis C
Curing Hepatitis C

Industry Reports and Publications

The following are publications of note from liver industry experts and relate to the need for better biomarkers to support therapuetic development and patient care: